Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 26, Issue 6, Pages 1128-1133
Publisher
Oxford University Press (OUP)
Online
2015-03-21
DOI
10.1093/annonc/mdv147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of angiotensin system inhibitors (ASI) on outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database.
- (2017) Rana R. McKay et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
- (2016) JOURNAL OF HYPERTENSION
- Incidence and Risk of Sorafenib-Induced Hypertension: A Systematic Review and Meta-Analysis
- (2014) Yan Li et al. Journal of Clinical Hypertension
- Angiotensin-Converting Enzyme Inhibitor Therapy and Colorectal Cancer Risk
- (2014) George A. Makar et al. JNCI-Journal of the National Cancer Institute
- Telmisartan Induces Growth Inhibition, DNA Double-Strand Breaks and Apoptosis in Human Endometrial Cancer Cells
- (2014) Naoko Koyama et al. PLoS One
- Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
- (2013) Brian I Rini et al. LANCET ONCOLOGY
- Metabolic Factors Associated with Risk of Renal Cell Carcinoma
- (2013) Christel Häggström et al. PLoS One
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) B. Escudier et al. ANNALS OF ONCOLOGY
- Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma
- (2011) Petri Bono et al. ACTA ONCOLOGICA
- Renin–angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice
- (2011) Masaya Kubota et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
- (2011) Úna C. Mc Menamin et al. CANCER CAUSES & CONTROL
- Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
- (2010) Y Nakai et al. BRITISH JOURNAL OF CANCER
- Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
- (2010) Sripal Bangalore et al. LANCET ONCOLOGY
- Epidemiology and risk factors for kidney cancer
- (2010) Wong-Ho Chow et al. Nature Reviews Urology
- From Theoretical Synergy to Clinical Supra-Additive Toxicity
- (2009) Jean-Charles Soria et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation